ArticlePlastic and reconstructive surgery. Global open2025
Interest in Facial Volume Restorative Procedures With the Rise in "Ozempic Face": A Google Trends Analysis.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasing in prevalence as the "go-to" medication for type 2 diabetes, obesity, and off-label weight loss. The changes associated with the use of these medications can result in an undesirable change in facial structure and skin quality, leading to a more aged appearance in users of these medications. This study aimed to identify whether increased public interest in these GLP-1RA-related face changes, a phenomenon termed "Ozempic face," is associated with increased interest in relevant corrective procedures. Methods: Google Trends searches for terms related to Ozempic face, and the relevant corrective procedures were statistically analyzed to assess correlative relationships. Results: A significant positive trend was present for all Ozempic face-related terms from June 2022 to June 2025, indicating an increase in search for these terms during this time period. There was a significant positive relationship between the increased interest in the facial weight loss-related terms and "filler" terms, but no significant relationship with surgical procedure terms. Conclusions: With the rapid rise in the number of patients on these medications, it is essential for any clinicians who prescribe them or those who follow up with patients who use them to increase their awareness of this phenomenon for appropriate patient counseling and treatment. This study highlights the growing role of facial aesthetic procedures in the care of GLP-1RA users. Our findings underscore the need for greater clinician education and continued research on the most effective and optimal methods for approaching these side effects.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.